Entecavir is Safe and Effective in Long Term for the Treatment of Hepatitis B in Immunocompromised Children-Reference-Cited by-同舟云学术

Entecavir is Safe and Effective in Long Term for the Treatment of Hepatitis B in Immunocompromised Children

Published:2020-03 Issue:2 Volume:10 Page:150-154
ISSN:0973-6883
Container-title:Journal of Clinical and Experimental Hepatology
language:en
Short-container-title:Journal of Clinical and Experimental Hepatology

Author:

Wani Manzoor A.,Sodhi Jaswinder S.,Zargar Showkat A.,Yatoo Ghulam N.,Shah Altaf,Aziz Sheikh A.,Geelani Sajad,Haq Inaamul,Gulzar Ghulam M.,Khan Mushtaq,Haq Inaamul

Publisher

Elsevier BV

Subject

Hepatology

Reference35 articles.

1. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013;Schweitzer;Lancet,2015

2. Prevention of hepatitis B in India, An Overview,2002

3. Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state;McMahon;J Infect Dis,1985

4. Management of chronic hepatitis B in childhood: ESPGHAN clinical practice guidelines: consensus of an expert panel on behalf of the European Society of Pediatric Gastroenterology, Hepatology and Nutrition;Sokal;J Hepatol,2013

5. The development of hepatocellular carcinoma among prospectively followed children with chronic hepatitis B virus infection;Wen;J Pediatr,2004

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of efficacy and safety of entecavir and switching from entecavir to tenofovir alafenamide fumarate in chronic hepatitis B: Long‐term effects from a prospective study;Hepatology Research;2021-05-07

2. Management of Hepatitis-B Virus Infection in Immunocompromised Children: A Single Center Experience;Journal of Pediatric Gastroenterology & Nutrition;2020-12-31

3. Effect of Entecavir on the Intestinal Microflora in Patients with Chronic Hepatitis B: A Controlled Cross-Sectional and Longitudinal Real-World Study;Infectious Diseases and Therapy;2020-10-28